April 13, 2025 - 08:01

In a significant move to bolster its export sector, the UK government announced an expansion of financing support for exporters, making an additional £20 billion (approximately $26 billion) available. This initiative aims to provide much-needed stability and certainty for businesses navigating the complexities of a shifting global trade landscape.
The decision comes in the wake of heightened uncertainty stemming from tariffs imposed by the United States under the previous administration. These tariffs, which include a 25% levy on steel, aluminium, and automotive imports, along with a 10% baseline tariff on various other goods, have raised concerns among UK exporters about their competitiveness and market access.
By expanding financial assistance, the UK government aims to mitigate the impact of these tariffs and support businesses in adapting to the new trade environment. This initiative is part of a broader strategy to enhance the resilience of UK exporters as they face ongoing challenges in international markets. The government emphasizes its commitment to fostering a robust export economy in this evolving landscape.
May 9, 2026 - 22:04
Compass Diversified Q1 Earnings Call HighlightsCompass Diversified, the publicly traded holding company known as CODI, reported its first-quarter 2026 earnings this week, with management framing the period as one of disciplined execution. Chief...
May 9, 2026 - 00:34
Urbana Corporation Has Filed 2026 First Quarter Interim Financial StatementsTORONTO - Urbana Corporation has submitted its unaudited interim financial statements and management discussion for the first quarter of 2026. The filing covers the three-month period ending March...
May 8, 2026 - 11:59
Australia regulator calls for urgent cybersecurity action to counter MythosAustralia`s corporate watchdog has called on the country`s financial industry to take urgent steps to address cybersecurity risks posed by advanced artificial intelligence systems, including a...
May 7, 2026 - 20:22
IN8bio Reports First Quarter 2026 Financial Results and Recent Business HighlightsIN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The...